Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

STAT+: Bladder cancer immunotherapy from CG Oncology reduced risk of tumor recurrence

CG Oncology's bladder cancer immunotherapy reduced risk of tumor recurrence by 68% — results that may change how physicians treat certain patients.

STAT+: Bladder cancer immunotherapy from CG Oncology reduced risk of tumor recurrence

We haven't written up this one. STAT News has the full story — the link below goes straight to it.

Read the original at statnews.com →

More in Health & Medicine

More from Monday 16 November →